VALTREX is indicated for the treatment of herpes zoster (shingles). Valtrex accelerates the resolution of pain: it reduces the duration of and the proportion of patients with zoster-associated pain, which includes acute and post-herpetic neuralgia.
VALTREX is indicated for the treatment of herpes simplex infections of the skin and mucous membranes, including initial and recurrent genital herpes.
VALTREX can prevent lesion development when taken at the first signs and symptoms of an HSV recurrence.
VALTREX is indicated for the prevention (suppression) of recurrent herpes simplex infections of the skin and mucous membranes, including genital herpes.
VALTREX can reduce transmission of genital herpes when taken as suppressive therapy and combined with safer sex practices (particularly the use of condoms).